Evans D G, Bourn D, Wallace A, Ramsden R T, Mitchell J D, Strachan T
Department of Medical Genetics, St Mary's Hospital, Manchester, UK.
J Med Genet. 1995 Jun;32(6):470-4. doi: 10.1136/jmg.32.6.470.
We report a family with type 2 neurofibromatosis and late onset tumours. Five members of this family have developed hearing loss late in life, two of whom have only been shown to have the diagnosis in their seventies, and three other obligate gene carriers died undiagnosed at 64, 72, and 78 years of age. A missense mutation at the C-terminal end of the NF2 protein has been identified in this family and segregates with disease. The use of highly polymorphic markers for predictive testing is also shown. There appears to be an autosomal dominant form of spinocerebellar degeneration which is segregating separately to NF2 in this family, which created a diagnostic dilemma.
我们报告了一个患有2型神经纤维瘤病和迟发性肿瘤的家族。该家族的五名成员在晚年出现了听力丧失,其中两人直到七十多岁才被确诊,另外三名肯定的基因携带者分别在64岁、72岁和78岁时未被诊断就去世了。在这个家族中已鉴定出NF2蛋白C末端的一个错义突变,且该突变与疾病相关。还展示了使用高度多态性标记进行预测性检测的情况。在这个家族中,似乎有一种常染色体显性形式的脊髓小脑变性,它与NF2是分别遗传的,这造成了诊断上的困境。